Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 240

1.

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.

Sparano JA, Gray RJ, Ravdin PM, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW Jr.

N Engl J Med. 2019 Jun 20;380(25):2395-2405. doi: 10.1056/NEJMoa1904819. Epub 2019 Jun 3.

PMID:
31157962
2.

Multidisciplinary Approaches to Chest Wall Recurrences of Breast Cancer.

Arciero C, Thompson P, Meisel JL, Taylor CE, Torres MA, Wood WC.

Oncology (Williston Park). 2018 Aug 15;32(8):392-6, 417. Review.

3.

Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth?

Johnson AC, Ethun CG, Liu Y, Lopez-Aguiar AG, Tran TB, Poultsides G, Grignol V, Howard JH, Bedi M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Delman KA, Wood WC, Cardona K, Maithel SK.

J Am Coll Surg. 2018 Sep;227(3):357-366.e3. doi: 10.1016/j.jamcollsurg.2018.05.009. Epub 2018 Jun 12.

PMID:
29906615
4.

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Ravdin PM, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW Jr.

N Engl J Med. 2018 Jul 12;379(2):111-121. doi: 10.1056/NEJMoa1804710. Epub 2018 Jun 3.

5.

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.

Rakovitch E, Gray R, Baehner FL, Sutradhar R, Crager M, Gu S, Nofech-Mozes S, Badve SS, Hanna W, Hughes LL, Wood WC, Davidson NE, Paszat L, Shak S, Sparano JA, Solin LJ.

Breast Cancer Res Treat. 2018 Jun;169(2):359-369. doi: 10.1007/s10549-018-4693-2. Epub 2018 Jan 31.

7.

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

Rugo HS, Olopade OI, DeMichele A, Yau C, van 't Veer LJ, Buxton MB, Hogarth M, Hylton NM, Paoloni M, Perlmutter J, Symmans WF, Yee D, Chien AJ, Wallace AM, Kaplan HG, Boughey JC, Haddad TC, Albain KS, Liu MC, Isaacs C, Khan QJ, Lang JE, Viscusi RK, Pusztai L, Moulder SL, Chui SY, Kemmer KA, Elias AD, Edmiston KK, Euhus DM, Haley BB, Nanda R, Northfelt DW, Tripathy D, Wood WC, Ewing C, Schwab R, Lyandres J, Davis SE, Hirst GL, Sanil A, Berry DA, Esserman LJ; I-SPY 2 Investigators.

N Engl J Med. 2016 Jul 7;375(1):23-34. doi: 10.1056/NEJMoa1513749.

8.

Adaptive Randomization of Neratinib in Early Breast Cancer.

Park JW, Liu MC, Yee D, Yau C, van 't Veer LJ, Symmans WF, Paoloni M, Perlmutter J, Hylton NM, Hogarth M, DeMichele A, Buxton MB, Chien AJ, Wallace AM, Boughey JC, Haddad TC, Chui SY, Kemmer KA, Kaplan HG, Isaacs C, Nanda R, Tripathy D, Albain KS, Edmiston KK, Elias AD, Northfelt DW, Pusztai L, Moulder SL, Lang JE, Viscusi RK, Euhus DM, Haley BB, Khan QJ, Wood WC, Melisko M, Schwab R, Helsten T, Lyandres J, Davis SE, Hirst GL, Sanil A, Esserman LJ, Berry DA; I-SPY 2 Investigators.

N Engl J Med. 2016 Jul 7;375(1):11-22. doi: 10.1056/NEJMoa1513750.

9.

Improving Breast Ultrasound Interpretation in Uganda Using a Condensed Breast Imaging Reporting and Data System.

Scheel JR, Peacock S, Orem J, Bugeza S, Muyinda Z, Porter PL, Wood WC, Comis RL, Lehman CD.

Acad Radiol. 2016 Oct;23(10):1271-7. doi: 10.1016/j.acra.2016.05.018. Epub 2016 Jun 17.

PMID:
27325412
10.

Ductal Carcinoma In Situ of the Breast: Should Breast Irradiation Be Routinely Added to Surgical Excision?

Wood WC.

J Oncol Pract. 2016 Apr;12(4):309-11. doi: 10.1200/JOP.2015.010488. Review.

PMID:
27072386
11.

Reply to C. Shah et al.

Solin LJ, Gray R, Hughes LL, Wood WC, Lowen MA, Badve SS, Baehner FL, Ingle JN, Perez EA, Recht A, Sparano JA, Davidson NE.

J Clin Oncol. 2016 May 20;34(15):1824-5. doi: 10.1200/JCO.2016.66.4714. Epub 2016 Mar 21. No abstract available.

PMID:
27001578
12.

Real Personalized Medicine.

Armitage JO, Wood WC, Longo DL.

J Natl Compr Canc Netw. 2016 Feb;14(2):233-6. No abstract available.

PMID:
26850491
13.

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.

Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Perez EA, Olson JA Jr, Zujewski J, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Ravdin P, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Atkins JN, Berenberg JL, Sledge GW.

N Engl J Med. 2015 Nov 19;373(21):2005-14. doi: 10.1056/NEJMoa1510764. Epub 2015 Sep 27.

14.

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.

Solin LJ, Gray R, Hughes LL, Wood WC, Lowen MA, Badve SS, Baehner FL, Ingle JN, Perez EA, Recht A, Sparano JA, Davidson NE.

J Clin Oncol. 2015 Nov 20;33(33):3938-44. doi: 10.1200/JCO.2015.60.8588. Epub 2015 Sep 14.

15.

Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer.

Sparano JA, Zhao F, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE.

J Clin Oncol. 2015 Jul 20;33(21):2353-60. doi: 10.1200/JCO.2015.60.9271. Epub 2015 Jun 15.

16.

The current clinical value of the DCIS Score.

Wood WC, Alvarado M, Buchholz DJ, Hyams D, Hwang S, Manders J, Park C, Solin LJ, White J, Willey S.

Oncology (Williston Park). 2014 May;28 Suppl 2:C2, 1-8, C3.

17.

Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group.

Tevaarwerk AJ, Wang M, Zhao F, Fetting JH, Cella D, Wagner LI, Martino S, Ingle JN, Sparano JA, Solin LJ, Wood WC, Robert NJ.

J Clin Oncol. 2014 Dec 10;32(35):3948-58. doi: 10.1200/JCO.2014.55.6993. Epub 2014 Oct 27.

18.

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ, Wolff AC, Wood WC, Davidson NE, Sledge GW, Sparano JA, Badve SS.

J Clin Oncol. 2014 Sep 20;32(27):2959-66.

19.

uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.

Yang L, Sajja HK, Cao Z, Qian W, Bender L, Marcus AI, Lipowska M, Wood WC, Wang YA.

Theranostics. 2013 Dec 17;4(1):106-18. doi: 10.7150/thno.7409. eCollection 2013.

20.

Reply to P.G. Tsoutsou et al, o. Kaidar-Person et al, and A. Courdi et al.

Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP, Wood WC.

J Clin Oncol. 2013 Dec 20;31(36):4571-3. doi: 10.1200/JCO.2013.52.9438. Epub 2013 Nov 4. No abstract available.

PMID:
24190113
21.

Ductal carcinoma in situ of the breast: 'making the punishment fit the crime'.

Wood WC.

Oncology (Williston Park). 2013 Aug;27(8):796-7. No abstract available.

22.

Close/positive margins after breast-conserving therapy: additional resection or no resection?

Wood WC.

Breast. 2013 Aug;22 Suppl 2:S115-7. doi: 10.1016/j.breast.2013.07.022. Review.

PMID:
24074771
23.

Patent foramen ovale and cryptogenic stroke.

Wood WC, Switchenko JM.

N Engl J Med. 2013 Jul 4;369(1):88. doi: 10.1056/NEJMc1305429. No abstract available.

PMID:
23822783
24.

Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.

Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP, Wood WC.

J Clin Oncol. 2013 Jul 1;31(19):2382-7. doi: 10.1200/JCO.2012.45.2615. Epub 2013 May 20.

25.

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.

Solin LJ, Gray R, Baehner FL, Butler SM, Hughes LL, Yoshizawa C, Cherbavaz DB, Shak S, Page DL, Sledge GW Jr, Davidson NE, Ingle JN, Perez EA, Wood WC, Sparano JA, Badve S.

J Natl Cancer Inst. 2013 May 15;105(10):701-10. doi: 10.1093/jnci/djt067. Epub 2013 May 2.

26.

Final results from phase II trial of neoadjuvant docetaxel and capecitabine given sequentially or concurrently for HER2-negative breast cancers.

Zelnak AB, Styblo TM, Rizzo M, Gabram SG, Wood WC, Harichand-Herdt S, Kim S, Liu Y, O'Regan RM; Georgia Center for Oncology Research and Education.

Clin Breast Cancer. 2013 Jun;13(3):173-9. doi: 10.1016/j.clbc.2012.12.004. Epub 2013 Jan 16.

PMID:
23332349
27.

Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer.

Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Fetting J, Davidson NE.

Cancer. 2012 Dec 1;118(23):5937-46. doi: 10.1002/cncr.27527. Epub 2012 Aug 27.

28.

Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer.

Schneider BP, Zhao F, Wang M, Stearns V, Martino S, Jones V, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE, Sparano JA.

J Clin Oncol. 2012 Sep 1;30(25):3051-7. doi: 10.1200/JCO.2011.39.8446. Epub 2012 Jul 30.

29.

An acute animal model of aortic stenosis: initial attempts at leaflet modification.

Anderson CA, Wood WC, DiBernardo L, Erdmann M, Kypson AP.

J Heart Valve Dis. 2012 Mar;21(2):172-4.

PMID:
22645851
30.

Locoregional recurrence after mastectomy with immediate transverse rectus abdominis myocutaneous (TRAM) flap reconstruction.

Patterson SG, Teller P, Iyengar R, Carlson GW, Gabram-Mendola SG, Losken A, Styblo T, Torres M, Wood WC, Perez SD, Mosunjac M, Rizzo M.

Ann Surg Oncol. 2012 Aug;19(8):2679-84. doi: 10.1245/s10434-012-2329-z. Epub 2012 Apr 3.

PMID:
22476750
31.

Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.

Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE.

J Natl Cancer Inst. 2012 Mar 7;104(5):406-14. doi: 10.1093/jnci/djr543. Epub 2012 Jan 16.

32.

The changing field of locoregional treatment for breast cancer.

Rizzo M, Wood WC.

Oncology (Williston Park). 2011 Aug;25(9):813-6. Review.

33.

EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.

Lam S, Boyle P, Healey GF, Maddison P, Peek L, Murray A, Chapman CJ, Allen J, Wood WC, Sewell HF, Robertson JF.

Cancer Prev Res (Phila). 2011 Jul;4(7):1126-34. doi: 10.1158/1940-6207.CAPR-10-0328.

34.

Restrospective on the last quarter-century in surgical oncology.

Wood WC.

Oncology (Williston Park). 2011 Apr 30;25(5):397-8. No abstract available.

35.

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.

Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ; Panel members.

Ann Oncol. 2011 Aug;22(8):1736-47. doi: 10.1093/annonc/mdr304. Epub 2011 Jun 27.

36.

Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis.

Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC 2nd, McMasters KM, Cho CS, Winslow ER, Wood WC, Staley CA 3rd.

J Am Coll Surg. 2011 Apr;212(4):638-48; discussion 648-50. doi: 10.1016/j.jamcollsurg.2011.01.004.

37.

Cooperation in clinical trials.

Wood WC.

J Am Coll Surg. 2011 Apr;212(4):431-9. doi: 10.1016/j.jamcollsurg.2011.01.039. No abstract available.

PMID:
21463764
38.

Management of axillary lymph node metastasis in breast cancer: making progress.

Carlson GW, Wood WC.

JAMA. 2011 Feb 9;305(6):606-7. doi: 10.1001/jama.2011.131. No abstract available.

PMID:
21304087
39.

Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group.

Rao RD, Cobleigh MA, Gray R, Graham ML 2nd, Norton L, Martino S, Budd GT, Ingle JN, Wood WC.

Med Oncol. 2011 Dec;28 Suppl 1:S39-47. doi: 10.1007/s12032-010-9682-1. Epub 2010 Sep 28.

40.

Clinical validation of an autoantibody test for lung cancer.

Boyle P, Chapman CJ, Holdenrieder S, Murray A, Robertson C, Wood WC, Maddison P, Healey G, Fairley GH, Barnes AC, Robertson JF.

Ann Oncol. 2011 Feb;22(2):383-9. doi: 10.1093/annonc/mdq361. Epub 2010 Jul 30.

41.

Non-invasive anatomy and physiology: the new 'gold standard'?

Wood WC.

Heart. 2010 Mar;96(6):411-2. doi: 10.1136/hrt.2009.183731. Epub 2009 Nov 27. No abstract available.

PMID:
19945996
42.

Should the use of contralateral prophylactic mastectomy be increasing as it is?

Wood WC.

Breast. 2009 Oct;18 Suppl 3:S93-5. doi: 10.1016/S0960-9776(09)70282-6.

PMID:
19914552
43.

Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.

Hughes LL, Wang M, Page DL, Gray R, Solin LJ, Davidson NE, Lowen MA, Ingle JN, Recht A, Wood WC.

J Clin Oncol. 2009 Nov 10;27(32):5319-24. doi: 10.1200/JCO.2009.21.8560. Epub 2009 Oct 13.

44.

Multiplexed fluorescence imaging of tumor biomarkers in gene expression and protein levels for personalized and predictive medicine.

Smith MQ, Staley CA, Kooby DA, Styblo T, Wood WC, Yang L.

Curr Mol Med. 2009 Nov;9(8):1017-23. Review.

45.

Mentoring in psychiatric residency programs: a survey of chief residents.

Lis LD, Wood WC, Petkova E, Shatkin J.

Acad Psychiatry. 2009 Jul-Aug;33(4):307-12. doi: 10.1176/appi.ap.33.4.307.

PMID:
19690111
46.

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

Yang L, Peng XH, Wang YA, Wang X, Cao Z, Ni C, Karna P, Zhang X, Wood WC, Gao X, Nie S, Mao H.

Clin Cancer Res. 2009 Jul 15;15(14):4722-32. doi: 10.1158/1078-0432.CCR-08-3289. Epub 2009 Jul 7.

47.

Multidetector CT: a new "window" adding to the echocardiographic assessment of prosthetic aortic valves?

Wood WC.

J Cardiovasc Comput Tomogr. 2009 May-Jun;3(3):168-9. doi: 10.1016/j.jcct.2009.04.005. Epub 2009 May 8. No abstract available.

PMID:
19527892
48.

Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.

Yang L, Mao H, Cao Z, Wang YA, Peng X, Wang X, Sajja HK, Wang L, Duan H, Ni C, Staley CA, Wood WC, Gao X, Nie S.

Gastroenterology. 2009 May;136(5):1514-25.e2. doi: 10.1053/j.gastro.2009.01.006. Epub 2009 Jan 14.

49.

Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.

Yang L, Mao H, Wang YA, Cao Z, Peng X, Wang X, Duan H, Ni C, Yuan Q, Adams G, Smith MQ, Wood WC, Gao X, Nie S.

Small. 2009 Feb;5(2):235-43. doi: 10.1002/smll.200800714.

50.

Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging.

Yang L, Cao Z, Sajja HK, Mao H, Wang L, Geng H, Xu H, Jiang T, Wood WC, Nie S, Wang YA.

J Biomed Nanotechnol. 2008 Dec 1;4(4):439-449.

Supplemental Content

Support Center